Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Davis

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Journal of Medical Virology|May 25, 2006
Neutralization kinetics of sensitive and resistant subtype B primary human immunodeficiency virus type 1 isolatesDavid Davis, Helen Donners, Betty Willems, et al.
Academic Pediatrics|April 24, 2018
Modernizing Training on Social Determinants of Health: A Virtual Neighborhood Tour is Noninferior to an in-Person ExperienceMargot A Lazow, Francis J Real, Nicholas J Ollberding, et al.
Education for Health (Abingdon, England)|May 23, 2018
Resident perspectives on communication training that utilizes immersive virtual realityFrancis J Real, Dominick DeBlasio, Nicholas J Ollberding, et al.
Plos One|August 27, 2013
In vitro neutralization of low dose inocula at physiological concentrations of a monoclonal antibody which protects macaques against SHIV challengeDavid Davis, Wim Koornstra, Zahra Fagrouch, et al.
AIDS Research and Human Retroviruses|November 6, 2009
HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodiesTessa Dieltjens, Nathalie Loots, Katleen Vereecken, et al.
Plos One|January 5, 2012
Protection in macaques immunized with HIV-1 candidate vaccines can be predicted using the kinetics of their neutralizing antibodiesDavid Davis, Wim Koornstra, Daniella Mortier, et al.
Journal of the American Chemical Society|February 24, 2011
Synthesis of a trimeric gp120 epitope mimic conjugated to a T-helper peptide to improve antigenicityJoan G Schellinger, Lieza M Danan-Leon, Jessica A Hoch, et al.
Journal of Medical Virology|July 13, 2002
In vitro susceptibility to infection with SIVcpz and HIV-1 is lower in chimpanzee than in human peripheral blood mononuclear cellsPascale Ondoa, David Davis, Luc Kestens, et al.
Journal of Medical Education and Curricular Development|April 8, 2022
Design, Implementation and Evaluation of a Distance Learning Framework to Expedite Medical Education during COVID-19 pandemic: A Proof-of-Concept StudyAida J Azar, Amar Hassan Khamis, Nerissa Naidoo, et al.
American Journal of Ophthalmology|March 26, 2013
Endothelial keratoplasty: prospective, randomized, masked clinical trial comparing an injector with forceps for tissue insertionMark A Terry, Michael D Straiko, Jeffrey M Goshe, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Journal of Medical Virology|May 25, 2006
Neutralization kinetics of sensitive and resistant subtype B primary human immunodeficiency virus type 1 isolatesDavid Davis, Helen Donners, Betty Willems, et al.
Academic Pediatrics|April 24, 2018
Modernizing Training on Social Determinants of Health: A Virtual Neighborhood Tour is Noninferior to an in-Person ExperienceMargot A Lazow, Francis J Real, Nicholas J Ollberding, et al.
Education for Health (Abingdon, England)|May 23, 2018
Resident perspectives on communication training that utilizes immersive virtual realityFrancis J Real, Dominick DeBlasio, Nicholas J Ollberding, et al.
Plos One|August 27, 2013
In vitro neutralization of low dose inocula at physiological concentrations of a monoclonal antibody which protects macaques against SHIV challengeDavid Davis, Wim Koornstra, Zahra Fagrouch, et al.
AIDS Research and Human Retroviruses|November 6, 2009
HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodiesTessa Dieltjens, Nathalie Loots, Katleen Vereecken, et al.
Plos One|January 5, 2012
Protection in macaques immunized with HIV-1 candidate vaccines can be predicted using the kinetics of their neutralizing antibodiesDavid Davis, Wim Koornstra, Daniella Mortier, et al.
Journal of the American Chemical Society|February 24, 2011
Synthesis of a trimeric gp120 epitope mimic conjugated to a T-helper peptide to improve antigenicityJoan G Schellinger, Lieza M Danan-Leon, Jessica A Hoch, et al.
Journal of Medical Virology|July 13, 2002
In vitro susceptibility to infection with SIVcpz and HIV-1 is lower in chimpanzee than in human peripheral blood mononuclear cellsPascale Ondoa, David Davis, Luc Kestens, et al.
Journal of Medical Education and Curricular Development|April 8, 2022
Design, Implementation and Evaluation of a Distance Learning Framework to Expedite Medical Education during COVID-19 pandemic: A Proof-of-Concept StudyAida J Azar, Amar Hassan Khamis, Nerissa Naidoo, et al.
American Journal of Ophthalmology|March 26, 2013
Endothelial keratoplasty: prospective, randomized, masked clinical trial comparing an injector with forceps for tissue insertionMark A Terry, Michael D Straiko, Jeffrey M Goshe, et al.
Pageof 10